-
Signature
-
/s/ Brian E. Anderson, attorney-in-fact for Leah Tate
-
Issuer symbol
-
BDC
-
Transactions as of
-
13 May 2025
-
Net transactions value
-
-$46,761
-
Form type
-
4
-
Filing time
-
14 May 2025, 17:41:49 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Tate Leah |
SVP - HR |
C/O BELDEN INC., 1 N. BRENTWOOD BLVD., 15TH FLOOR, ST. LOUIS |
/s/ Brian E. Anderson, attorney-in-fact for Leah Tate |
14 May 2025 |
0001916589 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BDC |
Common Stock |
Options Exercise |
$142,979 |
+1,667 |
+5.5% |
$85.77 |
31,837 |
13 May 2025 |
Direct |
F1 |
| transaction |
BDC |
Common Stock |
Disposed to Issuer |
$163,489 |
-1,436 |
-4.5% |
$113.85 |
30,401 |
13 May 2025 |
Direct |
F2 |
| transaction |
BDC |
Common Stock |
Sale |
$26,251 |
-231 |
-0.76% |
$113.64 |
30,170 |
14 May 2025 |
Direct |
F4 |
| holding |
BDC |
Common Stock |
|
|
|
|
|
3,360 |
13 May 2025 |
By Spouse |
|
| holding |
BDC |
Common Stock |
|
|
|
|
|
1,164 |
13 May 2025 |
By 401(k) Plan |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BDC |
Stock Appreciation Rights |
Options Exercise |
$0 |
-1,667 |
-50% |
$0.000000 |
1,666 |
13 May 2025 |
Common Stock |
1,667 |
$85.77 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: